Term ends May 23, 2031 · High confidence
20-year base term ends May 23, 2031
Filed Dec 12, 2012 as application 13/699,589 · Granted Sep 1, 2015
Base term, 20 years from filing
Today
2011
2031
Clock starts
May 23, 2011
May 23, 2011
Term ends
May 23, 2031
May 23, 2031
Granted
Sep 1, 2015
Sep 1, 2015
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 23, 2011, when application PCT/AT2011/000237, the earliest non-provisional in its chain, was filed (this one was filed Dec 12, 2012) | May 23, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 23, 2031 | High confidence |
Partial family
| Application PCT/AT2011/000237 | PCT application no patent term | no patent term |
| US 9,120,727 | this patent May 2031 | May 2031 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 10, 2012 Reel 29439, frame 875 | Riedl, Rosemarie; Heilmayer, Werner; Spence, Lee | Nabriva Therapeutics AG | Assignment of Assignor's Interest |
| Sep 3, 2014 Reel 33659, frame 216 | Nabriva Therapeutics AG | Kreos Capital IV (UK) Limited | Lien |
| Nov 19, 2015 Reel 37093, frame 308 | Kreos Capital IV (UK) Limited | Nabriva Therapeutics AG | Release of Security Interest |
| Dec 2, 2015 Reel 37190, frame 424 | Kreos Capital IV (UK) Limited | Nabriva Therapeutics AG | Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement. |
| May 17, 2018 Reel 47658, frame 862 | Nabriva Therapeutics AG | Nabriva Therapeutics GmbH | Change of Name |
| Dec 20, 2018 Reel 47973, frame 110 | Nabriva Therapeutics GmbH | Hercules Capital, Inc. | Intellectual Property Security Agreement |
| Jan 18, 2019 Reel 48062, frame 807 | Nabriva Therapeutics GmbH | Hercules Capital, Inc. | Security Interest |
| Mar 3, 2023 Reel 62881, frame 90 | Hercules Capital, Inc. | Nabriva Therapeutics GmbH; Zavante Therapeutics, Inc. | Release of Security Interest |
| Mar 3, 2023 reel/frame not recorded | Hercules Capital, Inc. | Nabriva Therapeutics GmbH | Release of Security Interest |
| Mar 3, 2023 reel/frame not recorded | Hercules Capital, Inc. | Zavante Therapeutics, Inc. | Release of Security Interest |
| Jun 20, 2023 Reel 64312, frame 350 | Hercules Capital, Inc. | Nabriva Therapeutics GmbH | Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. |
| Jan 9, 2025 Reel 69806, frame 458 | Nabriva Therapeutics GmbH | Hong Kong King-Friend Industrial Company Ltd. | Assignment of Assignor's Interest |
| Apr 3, 2025 Reel 70725, frame 291 | Nabriva Therapeutics GmbH | Hong Kong King-Friend Industrial Company Ltd. | Nunc Pro Tunc Assignment |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2031
Term ends May 23, 2031. Maintenance fees still fall due before then
Citations
13
later US patents cite this one
That is above the median of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.